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Clinical trial of a milk formula for
infants of low birth weight
J. C. THOM, G. DE JONG, T. J. VAN N. KOTZE
Summary
An infant milk formula specially designed to meet the
specific needs of the small premature infant was
compared with a modified infant milk formula in
common use.
Healthy infants of very low birth weight were fed with
either the specially designed infant milk formula or the
standard modified infant milk formula.
No statistically significant differences between the
two groups of infants were found, although the weight
gain, skinfold thick'ness, serum total protein. alQumin
and calcium values were marginally better at 28 days
in the group fed with the specially designed formula.
S Atr Med J1984; 65: 125-127.
The small premature baby fed on pooled human milk or various
standard formulas not only fails to achieve intra-uterine growth
rates, 1,2 but may develop overt or subclinical nutritional deficien-
cies3 such as demineralization of the skeleton.4
An JUant milk formula, Alprem*, which has been designed to
meet the specific nutritional needs of the small premarure infant,
was developed by the Scientific and Marketing Development
Section of the Infant Food and Dietetic Products Division,
Nestle, Vevey, Switzerland.
This srudy was undertaken to evaluate this formula clinically.
Patients and methods
Healthy Coloured infants with a birth weight of I 500 g or less
were assessed. They had either been born at Tygerberg Hospital
or had been admitted to the hospital soon after birth. Informed
consent was obtained from the mothers for admission to the trial.
The infants were fed with either Alprem or a modified infant
milk formula in common use, N an. Breast milk was not available
for the study. Infants were randomly allocated to the two groups,
the feeding regimens being similar in all respects except the type
of milk product used.
Clinical examination took place on admission to the ttial. The
gestational age of each infant was estimated according to the
Dubowitz method. 5 Those infants with a gestational age of more
than 34 weeks were evaluated according to the growth charts
compiled by Jaroszewicz ee al. 6 These charts, compiled for
Coloured infants, are not reliable for the evaluation of infants
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with a gestational age ofless than 34 weeks, for whom the growth
chans of Gairdner and Pearson7 were used.
A Berkel baby scale (accurate to 2 g) was used to weigh the
babies daily throughout the trial. An accurate measuring device
was used to determine crown-to-heellength on the 1st day oflife
and at weekly intervals thereafter. A metal measuring tape was
used to measure the head circumference after birth and at weekly
intervals thereafter.
Skinfold thickness was measured with a Harpenden caliper
over the triceps area midway between the acromion and
olecranon processes. The mean of three measurements was used.
Blood for biochemical and haematological srudies was collected
by venepuncture from each infant on entry to the trial and
fortnightly there3.fter. Urine samples for a 24-hour period were
collected 'on the 1st day of life and at 2-weekly intervals for
osmolality estimations. Blood and urine were analysed in the
biochemistry and haematological departments of Tygerberg
Hospital according to accepted methods of laboratory practice.
The infants were evaluated daily. Weight gain, volume of
feeds taken, number and consistency of the stools and the
physical well-being of the infant were assessed. Infants were
excluded from the trial if they had a serious illness or whenever
illness necessitated discontinuation of enteral feeds.
Descriptive statistics were used to assess the data and to srudy
the distributions of the 73 continuous variables measured. The
means and standard deviations of the important variables were
obtained, together with the approximate probabilities ofexceed-
ing the calculated values in the Srudent's e test (with the Welsh
modification) whenever the standard deviation of the two
samples was different.
Chi-square tests were applied to assess the presence or absence
ofconjunctivitis, respiratory distress syndrome, other respiratory
diseases and jaundice..
Results
The two groups ofinfants were comparable as regards gestational
age, birth weight and sex (Table I). .
The Alprem group initially consisted of 35 infants; 21 infants
were available for assessment at 28 days, and 7 at 42 days. The
TABLE I. CLINICAL CHARACTERISTICS OF THE
STUDY GROUPS*
Alprem group Nan group P
Initial No. of
infants 35 30
Gestational
age (wks) 33,84 ± 1,282 33,86 ± 0,784 0,95
Sex ratio (F:M) 20:15 21:9 0,29
Birth weight (g) 1365 ± 152 1321 ± 156 0,37
Small for gesta-
tional age 35 25
"'Results expressed as mean ± SO where appropriate.
t N = 25 for gestational age and small for gestational age categories_
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Discussion
TABLE 11. COMPLICATIONS NECESSITATING EXCLUSION
FROM THE TRIAL BEFORE 28 DAVS
Minor complications did not warrant exclusion from the trial
(Table Ill).
The majority of infants arrained the Tygerberg Hospital
discharge weight of 2300 g after 28 days, leaving only a few
infants in each group for assessment at 42 days.
There are two schools of thought about the optimal nutrition of
the small premature infant. One group claims that the aim
should be to achieve postnatal growth rates similar to those ofthe
fetus which reaches full term.8 The other group believes that to
achieve this goal excessive demands will be made on the
immature gut and the other organs. They are apprehensive ofthe
metabolic consequences and are satisfied with a somewhat
slower growth rate. 2,9,10
The infant formula Alprem was designed to be more suited to
the needs of the small premature infant and not necessarily to
achieve intra-uterine growth rates. The formula provides approxi-
mately 3 g protein per kg bodyweight. This is in agreement with
the amoUDt calculated by Fomon er al. 3 to be necessary for the
optimal growth of small premature infants. The renal and
metabolic capacities of the infants in the present study were not
exceeded. Serum urea and CO2 content values were normal after
28 days and 42 days of formula feeding, as were the serum'
protein and albumin values.
The carbohydrates contained in Alprem are lactose and
glucose. Limited lactose intake is thought to be desirable in the
small premature infant who has retarded lacrase development, 11,12
while glucose is readily absorbed and provides imni~diate
energy. 13 The calcium content of Alprem (67 mg/loo kcai) has
been increased to provide more calcium than is pre~endy
available in infant formula milk feeds. This amount is inadequate
to ensure sufficient retention of Ca" according to Fomon er al.,
who have calculated that 132 mg/loo kcal Ca" needs, to be
absorbed. 3 However, the serum Ca" levels of the infants in the
trial were found to be normal.
Phosphate-deficiency rickets has been reported in small
premature infants fed exclusively on human milk. 14 The Alprem
formula has a higher phosphate content than human milk and
provides 40 mg/loo kcal phosphate, which is substantially less
than the approximate 70 mg/loo kcal required for optimal
growth and retention. 15
No statistically significant differences were found between the
serum sodium levels of the two groups, which were normal at 28
and 42 days. Balance studies have shown that small premature
infants need 3 mmol sodiurn/kg/d. 16 The sodium level in
Alprem is approximately 11 mmoVl or 2,2 mmoVkg/d when fed
at 200 mVkg/d. The sodium level in Nan is 7 mmoVl or 1,4
mmol/kg/d when fed at 200 mVkg/d.
The mean daily weight gain was 18 g for the Alprem study
group and 17 g for the Nan study group, which is less than the
intra-uterine growth rate - estimated to be approximately
30 g/d during the last 3 months of pregnancy. 3
Initially it was planned to select infants whose weights were
appropriate to their gestational age. Unfortunately this was not
found to be possible, and all healthy infants of very low birth
weight who could be fed enterally within a few days after birth
were entered into the trial. Eventually all of them were found to
be small for gestational age (Table I). The fact that all the infants
in the trial were small for dates may be due to a natural selection
of relatively more mature infants for the study group, the
relatively more mature infants being less liable to develop those
complications that preclude oral feeding.
No statistically significant differences in the many variables
studied were found between the two groups, although weight
gain, skinfold thickness and serum protein, albumin and calcium
values were initially marginally bener in the study group fed
with the special formula.
Conclusion
We would like to thank Nestle Infant and Dietetic Services fot the
supply of Alprem and for financial assistance.
Optimal feeding of the low-birth-weight infant should support
an acceptable rate ofgrowth without imposing excessive metabolic
stress. From the study results it can be concluded that no undue
metabolic stress was imposed on the infants in the study groups.
Initially the Alprem study group had a slight growth advantage
and compared favourably with infants fed the standard modified
infant formula. This initial advantage, however, was no longer
apparent at 42 days. Intra-uterine growth rates could not be
achieved.
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TABLE Ill. MINOR COMPLICATIONS
Conjunctivitis
Respiratory
disease
RDS-mild
Jaundice
RDS == respiratory distress syndrome.
Gastro-enteritis
Exchange transfusion
Septicaemia
Necrotizing enterocolitis
Pneumonia
Nan group initially consisted of30 infants; 20 were assessed at 28
days and 11 at 42 days.
The slight advantage of the AlpreJIl group of infants over the
Nan group as regards weight gain, growth in length, increase in
skinfold thickness and head circumference at 28 days, and
increase in serum total protein, albumin, calcium and magnesium
values at 42 days, was not statistically significant.
. The volume offormula feed consumed by the infants through-
out the trial was monitored very closely and found to be in
accordance with that of the feeding regimen.
The stools of both groups were normal in consistency and
number. No clinical signs of lactose intolerance were observed.
Urine collection for the 24-hour periods proved to be difficult,
especially in the females. It must therefore be assumed that in
some instances urine was lost by leakage, and that not all
specimens were truly 24-hour specimens.
The complications encountered in the two groups of infants
necessitating exclusion from the trial were gastro-enteritis,
pneumonia, septicaemia, necrotizing enterocolitis and exchange
transfusions (Table 11). A comparison of the two groups showed
no significant differences in the complications arising during the
first 28 days of the trial (x2 Sdf = 5,58; P = 0,35).
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Early
acute
introduction of milk feeds
infantile gastro-enteritis
•In
A controlled study
O. J. RANSOME, HERNA ROODE
Summary
A blind controlled trial was performed to test the
hypothesis that early introduction offull-strength cow's
milk (FCM) during an attack of acute infantile gastro-
enteritis does not prolong the course of the illness. A
total of 74 children matched for age was admitted to
the trial, which compared the effect of FCM with that of
graduated milk (the strength of which was gradually
increased). Thirteen children (17,5%) were withdrawn
because of lactose malabsorption; of those remaining,
29 were given FCM and 32 graduated milk. The mean
duration of diarrhoea was 2,62 days for those on FCM
and 2,64 days for those given graduated milk (P= 0,71,
not significant). Early introduction of FCM therefore
does not prolong the course of acute infantile gastro-
enteritis. Because of the prevalence of malnutrition in
South Africa the practice of giving Glear fluids or
diluted milk during an attack of gastro-enteritis is
unnecessary and dangerous.
S Aft Med J1984; lIS: 127-128.
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That milk feeds are responsible for prolonging the course of
acute infantile gastro-enteritis is a widely held belief. This view is
prevalent not only among the lay public but also among the
medical fraternity. The occurrence of temporary lactose mal-
absorption in some patients with alleviation of symptoms on
withdrawal of milk feeds is no doubt panly responsible for this
belief. The increase in the volume and frequency of stools due to
early feeding is also partly responsible. It has led to the
widespread practice ofstopping all milk feeds during an attack of
acute gastro-enteritis and to the reintroduction of milk in
gradually increasing concentrations once the stools have returned
to normal. 1,2 This practice is probably without risk in a well-
nourished population. We have, however, seen many cases of
iatrogenic kwashiorkor due to milk feeds being stopped following
an attack of acute gastro-enteritis in the Black and Coloured
populations that we serve. On questioning, the mothers fre-
quently say that they substituted weak tea for milk on their
doctor's advice and never reintroduced milk. The doctors were
reinforcing the lay belief that milk causes diarrhoea.
In our gastro-enteritis unit it is routine practice in patients
with acute gastro-enteritis requiring intravenous rehydration to
stop all oral feeds overnight and to reintroduce full-strength
cow's milk (FCM) the next day. Usually half the fluid require-
ments are given intravenously and half o~ally for 24 hours and
then the total requirement is given orally. If the diarrhoea
persists for more than 2 days the stools are tested for lactose by
the standard Clinitest method; if the test is positive a change is
made to a lactose-free formula. Our impression was that our
patients were not prejudiced by this routine; recent trials from
Britain3 and Australia4 have supponed this. In view of the·vital
imponance of maintaining adequate nutrition in our population,
we decided to conduct a prospective trial to test the hypothesis
